PAREXEL’s consulting business segment has launched a new service line designed to provide a focused, market-driven approach to regulatory outsourcing services, with a primary emphasis on post-approval regulatory activities. Through the new offering, the company will customize services for clients based on their needs and business challenges by combining expertise, operational approaches and technology.    “With the ever-changing regulatory environment, pharmaceutical companies face new cha...